MI2025 – Edmund Neo

Title:
Expanding our knowledge on infectious diseases, such as understanding vector biology or building better diagnostics, is currently hindered by reliable reagents

Abstract:
Ankyrons® are small, high-affinity binding reagents that are animal free recombinant proteins and are based on an ankyrin-repeat scaffold overcoming many of the limitations of traditional antibodies. At ProImmune, we are generating a growing catalog of Ankyron clones which currently covers 3,000+ targets across 100+ species including proteins from key infectious diseases such as Viruses (Dengue, Mpox, SARS Coronaviruses, etc.), Bacteria (Mycobacterium tuberculosis), Parasites (Malaria), Disease Vectors (Mosquitoes, Avian Species, Swine, etc.).

Ankyrons perform seamlessly across applications including immunofluorescence, immunohistochemistry, flow cytometry, and ELISA while offering critical advantages over antibodies. Unlike antibodies, the Ankyrons compact size enables superior cell and tissue penetration and precise imaging, while its Fc-free design eliminates background from Fc receptor binding. Discover how Ankyrons can advance your research with more reliable, flexible, and cost-effective alternatives to conventional antibodies.

Biography:
Edmund Neo is ProImmune’s Immunology Sales Manager based in Singapore representing ProImmune in the Asia-Pacific Region. Edmund graduated from the National University of Singapore and worked with Abbott Laboratories researching on the impact of mineral fortification on the aggregation of dairy proteins before joining ProImmune in 2019. He has played a pivotal role in the team supporting customers in both academia and corporate spaces across his region to achieve their research objectives.